Clinical Trial

Catestatin as a Novel Biomarker for Cardiovascular and Microvascular Involvement in Systemic Sclerosis

Name: Catestatin as a Novel Biomarker for Cardiovascular and Microvascular Involvement in Systemic Sclerosis — clinical trial record (NCT07209644)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study investigates the relationship between serum catestatin levels and systemic sclerosis (SSc), with a focus on cardiovascular involvement and microvascular alterations, to determine catestatin's potential as a biomarker of disease activity and severity.

Trial Details

NCT Number	NCT07209644
Lead Sponsor	Assiut University
Conditions	Systemic Sclerosis
Enrollment	70 participants
Start Date	2026-11-01
Primary Completion	2027-11-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-10-07